Kelley Collaboration Conference Series

The next installment in the IU Kelley School of Business Collaboration Conference series will take place on February 25. The new administration, leadership and legislation all contribute to the recent changes in how the FDA performs its role. At the same time, manufacturers of pharmaceutical products, nutritionals, medical devices and diagnostic equipment, and other medical technologies are constantly looking for new ways to distribute, market and sell their products. Many would say that the effects of this combination are putting businesses under more regulatory scrutiny, subjecting companies to more liability and delaying the availability of new products and therapies to healthcare providers and ultimately, the public. This program will bring experts from industry and the regulatory environment together to discuss whether this is indeed the case and review strategies for the future.

For a complete agenda and registration information, please see: http://kelley.iu.edu/CBLS/conferences/page19191.html

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


%d bloggers like this: